States hemodialysis population. While this endeavor remains steadfast in assuring the continued dominance of this policy for AVF preference, it fails to take into account a subset of the dialysis population who will fail to see the benefits of an AVF. This subset of patients may include the elderly, those with poor vasculature anatomy, those with slowly progressive CKD that are more likely to die than progress to ESRD, and those with an overall poor long-term prognosis and shortened life expectancy. Thus, in an effort to avoid numerous unnecessary surgical and interventional procedures with minimal to no gains in clinical outcomes, an individualized patient approach must be adopted. The CMS instituted quality incentive program (QIP) is designed to reward high AVF prevalence while also penalizing high CVC prevalence. The current model is devoid of case-based adjustment, thus penalties are disbursed to dialysis providers in accordance with a "one-size-fits-all" fistula only approach. The most suitable access for a patient remains the one that takes into account the characteristics unique to the individual patient with a primary focus on patient comfort, satisfaction, quality of life and clinical outcomes.
Introduction
Arteriovenous fistulas (AVFs), arteriovenous grafts (AVGs) and tunneled cuffed central venous catheters (CVCs) are the three main vascular accesses used for hemodialysis.
When one attempts to identify the characteristics associated with the ideal vascular access for hemodialysis, a series of imperative factors emerges. Firstly, the access must be appropriately selected based on the patients' overall characteristics (age, life expectancy, comorbidities, vascular anatomy, and personal preferences). Secondly, the access must be able to be consistently used for hemodialysis with minimal interventions, both surgical and endovascular, in order to maintain functionality. Third, it must be associated with the lowest infectious and thrombotic complication risk thus leading to the lowest associated costs. Finally and perhaps most importantly, it must offer superior patient survival and quality of life. (Figure 2 ). When patients who had a maturing AVF or AVG are included in this analysis, a staggering 81 percent of patients were noted to be using a catheter at HD initiation.(3) Among those patients who began HD with a catheter, 36 percent were still using a catheter at 1 year, whereas 51 percent had transitioned to an AVF. Among patients who began HD with an AVF, 83 percent were still using an AVF at 1 year. This suggests that while placement of an AVF is possible in a majority of patients, there remains a cohort that does not succeed with this intervention.
The recognition of these patients in whom the risks of an AVF outweigh the benefits requires the incorporation of a patient-centered approach to care with the elimination of a "one size fits all" approach. This approach allows for the acceptance of patients with advanced age, particular comorbid conditions or anatomical deficits in whom an AVF may not be the desired or most suitable option. (4) (5) (6) (7) (8) .
Despite the scenario described above, CMS instituted a quality incentive program (QIP) in 2012, with the incorporation of vascular access quality outcomes into its metric in 2014, which rewards high AVF prevalence and penalizes high CVC prevalence. It should be noted that for payment year 2015, vascular access constitutes 25% of the total QIP score (9), which can indeed have a substantial financial impact. What is even more disheartening is that these rewards, penalties and percentage allocations are done so without regard for the individual patient context, such that the clinical characteristics and preferences of the patient remain unincorporated into the ultimate goals of care. Rosas and Feldman in a cost-utility analysis concluded that the high risk of complications of temporary catheters as a bridge to AVF functionality and the overall low AVF maturation rate explains why a universal policy of fistula first for all incident dialysis patients may not optimize clinical outcomes.(10) They suggested that strong consideration should be given to a more patient-centered approach taking into account the likelihood of AVF maturation. It is precisely the "one size fits all approach" that has been an unfortunate misinterpretation of the goals set forth by the CMS and FFCL initiatives that this paper attempts to re-envision.
Individual Patient Context
The implications of the CMS QIP and the FFCL initiative are that catheter avoidance is either equally or more important than actual AVF use and this has led to the reconsideration of a "fistula only" approach. AVFs have a primary failure rate of 30-70% and a 1-year patency rate of 40-70%, with numerous procedures of varying success rates being frequently required to combat these outcomes (7, (11) (12) (13) leading to the vascular access dilemma faced by nephrologists. This dilemma may offer an explanation as to why, despite the increasing use of AVF in prevalent hemodialysis patients, the majority of patients initiating hemodialysis in the United States do so with a CVC. Allon has suggested the need for change in the current Medicare reimbursement policies that may be perpetuating the high CVC prevalence in those initiating dialysis. (14) From a percentage allocation perspective it can be deduced that CMS acknowledges there are certain subsets of patients that are better suited for AVGs. Their goal of 66% AVF prevalence implies that the remaining 34% of patients may be better suited with another form of vascular access. The FFBI's original goal was to decrease the CVC use to <10 percent for patients on hemodialysis longer than 90 days (15) (16) and so the remaining percentage of patients would be expected to obtain an AVG. A patient-centered approach to access management can be used to determine the proportion of the patient population who will reap the benefits of an AVF rather than be subjected to the risks of surgery and interventional procedures to place an AVF that will never function or allow the long-term benefits of an AVF to accrue. The "Triple Aim" of CMS is to improve the patient experience of care (including quality and satisfaction), improve the health of populations and reduce the per capita cost of health care.(17) The success of these objectives is more probable in a patient-centered approach to care. (Table 1) . These themes allow the provider to understand the despair often felt by patients undergoing this mental, physical and clinical transition. It is the responsibility of the healthcare provider to educate and counsel these patients in order to provide support is dealing with these crucial domains.
In an attempt to update their vascular access guidelines, European Renal Best Practice
Workgroup surveyed a panel of kidney patients, nephrologists, nurses, surgeons and radiologists. The objective of this study was to compare the views of the patients and clinicians with respect to the priority of access-related decisions. They discovered that patients assigned higher priority to decisions regarding managing adverse effects of arteriovenous access and patient involvement in care, while clinicians prioritized decisions around sustaining patients' access options, technical aspects of access creation, and optimizing fistula maturation and patency.(25) It should come as no surprise that patients and clinicians have differing concerns; however it should reinforce the necessity of shared decision making in order to establish a unified plan that is in line with the wishes and best interests of the patients.
Investigators from Wake Forest University conducted a prospective study to explore patients' desired versus experienced roles in treatment decisions, characterize perceptions of treatment outcomes, and identify important sources of information with respect to vascular procedures. Of the patients who had dialysis accesses placed, about a quarter felt confused or overloaded with the amount of information that they were provided and about half said that they only had one treatment recommended to them without alternative choices. (26) Shared decision making between patients and clinicians should take into account the patients' long-term prognosis, goals of care and vascular anatomy. The patient needs to fully understand the risks, benefits and burdens of vascular access placement and hemodialysis. It is only via this shared decision/patient centered model that a benefit can truly be conferred on the patient. While a discussion of whether renal replacement therapy should be offered to this population is beyond the scope of this article, it should be recognized that alterations in treatment algorithms must occur in order to provide the most appropriate therapy for this population.
Should the same "standard of care," i.e. FFCL, be applied to this population of dialysis patients? Moreover, if the same benefits conveyed to the younger cohort of dialysis patients are not transferable to this population, then should a case-mix adjustment for age exist in the QIP measures for vascular access? These questions must be addressed given that the majority of patients initiating hemodialysis do so with a CVC. (3) The dialysis population aged >75 presents an interesting challenge with respect to vascular access because their overall frailty and vast comorbidity burden make it unlikely that the perceived advantages of an AVF will materialize. This is reflected in a mortality rate of 30-50% within the first year of dialysis in this population. (27, 38) AVF is superior to AVG and CVC regardless of the patient's age, including in octogenarians. However, they also reported the mortality benefit of AVG over CVC might not apply to younger (18-48 years) or older (>89 years) age groups. (45) . Of course all these analyses are observational and subject to confounding as patients in whom an AVF is successfully constructed may be inherently healthier than those in whom AVF is either unsuccessful or not even attempted.
Perhaps one of the major arguments against CVCs is related to catheter-related bloodstream infections (CRBSI). Given their poor vasculature and propensity for AVF immaturity, the elderly population is more likely to have long term CVCs and the complications that may arise from their presence. However, reports have demonstrated equivocal (46) as well as lower (47) incidence of CRBSI amongst the elderly.
A major consideration in this population is quality of life. Upon commencement of dialysis, patients will be subjected to frequent cannulations, long periods of immobility during hemodialysis, post-dialysis fatigue and possibly frequent interventions to mature and maintain their vascular access. These, in addition to the other co-morbidities, physical limitations associated with aging, and polypharmacy may result in an overall poor quality of life. Thus, when applying a patient-centered approach to the elderly population, the vascular access must be chosen based on their individual characteristics. The Kidney Disease Outcome Quality Initiative (KDOQI) guidelines for hemodialysis vascular access (56) recommend that an AVF should be considered first, followed by AVG placement if AVF placement is not possible. Catheters should be avoided for HD and used only when other options listed are not available. With respect to order of creation, the following algorithm is suggested: the initial choice is that of a forearm radiocephalic fistula followed by a brachiocephalic fistula with the final option being that of a transposed brachiobasilic fistula in those with a failed forearm fistula. Should these options fail or be deemed improbable, the creation of a prosthetic AVG should be considered with a forearm loop graft preferable to a straight configuration.
Numerous factors contribute to the ideal vascular access. However, perhaps one of the most important prerequisites for an appropriate access is suitable vascular anatomy.
Preoperative evaluation is essential in order to realize the ultimate goal of an ideal access.
It is via this preoperative evaluation that a sequence of surgical options can be The four risk categories were low, moderate, high and very high based on total risk score.
These categories predicted risk of FTM to be 24, 34, 50, and 69%, respectively. It is precisely this type of scoring system of personalized risk assessment that is the core of a patient-centered delivery of care model. With applying such a model, patients can be spared from repeat surgical and interventional procedures and obtain the vascular access with the highest probability of use at initiation of renal replacement therapy.
The high primary failure rates and longer maturation times of AVFs lead to prolonged catheter use and its complications. While AVGs require more interventions to maintain patency than AVFs, when factoring in the high rate of primary failures in AVFs, the cumulative patency is virtually equivalent.
While AVFs may be more cost effective when applied to an ideal population, the costs of AVFs may exceed those for AVGs, especially when dealing with a population that has a high risk of primary AVF failure. AVFs are the preferred access for most patients, and that AVGs are still preferred to CVCs. They recommended that the AVF measure should be adjusted for conditions where an AVG might be an acceptable. These conditions included older age, diabetes, presence of vascular disease, and high BMI. The TEP further recommended that the AVF be counted only if it is being used with two needles and no dialysis catheter is present. It might further be suggested that patients' wishes be taken into account in developing metrics. If an elderly or frail patient decides after full education that they do not wish to have an AVF placed, is it appropriate to pressure them to do so?
It is these types of alterations to the current metrics that are necessary for the evolution of the QIP to make it more consistent with a patient-centered approach to care and avoid the placement of AVFs in unsuitable patients. The vascular access metrics must be aligned to encourage patient-centeredness based on medical appropriateness, patient preference, and quality of life while still recognizing the results of population studies.
Kliger describes as a balance scorecard approach to ESRD management which emphasizes that if CPMs are used to develop physician performance scores which are used to calculate physician reimbursement, then they serve not only as a quality improvement tool but also a driving force in determining the way care is provided. (75) The author further notes that the metrics used for quality reporting were developed from population studies of best practice and do not identify opportunities for individualizing 
